154 related articles for article (PubMed ID: 38566070)
1. Survey of lived experiences and challenges in hepatitis B management and treatment.
Freeland C; Adjei C; Wallace J; Wang S; Hicks J; Adda D; James C; Cohen C
BMC Public Health; 2024 Apr; 24(1):944. PubMed ID: 38566070
[TBL] [Abstract][Full Text] [Related]
2. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
[TBL] [Abstract][Full Text] [Related]
3. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
Allard NL; MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2015 Jun; 39(3):255-9. PubMed ID: 25716519
[TBL] [Abstract][Full Text] [Related]
8. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
9. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
Shiferaw F; Letebo M; Bane A
BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
[TBL] [Abstract][Full Text] [Related]
10. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.
Zhou K; Terrault NA
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):188-195.e4. PubMed ID: 31173892
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B discrimination: global responses requiring global data.
Freeland C; Qureshi A; Wallace J; Kabagambe K; Desalegn H; Munoz C; Lee D; Owusu-Ansah T; Adda D; Ndow G; Yousif S; Abdalla H; Kheir O; Tu T; Cohen C
BMC Public Health; 2024 Jun; 24(1):1575. PubMed ID: 38862929
[TBL] [Abstract][Full Text] [Related]
12. Facilitators and barriers to accessing hepatitis B care in the postpartum period among foreign-born New Yorkers: a qualitative analysis of case notes.
Tang LY; Pene F; Cherfas L; Schwartz J; Baquero MC
BMC Public Health; 2024 Jan; 24(1):116. PubMed ID: 38191335
[TBL] [Abstract][Full Text] [Related]
13. Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers.
Adjei CA; Stutterheim SE; Naab F; Ruiter RAC
PLoS One; 2019; 14(12):e0225830. PubMed ID: 31794577
[TBL] [Abstract][Full Text] [Related]
14. Social impacts of living with chronic hepatitis B in South Sudanese community in Australia.
Mude WW; Fisher CM; Richmond J; Gautier RL; Wallace J
Ethn Health; 2022 Apr; 27(3):529-541. PubMed ID: 32568555
[No Abstract] [Full Text] [Related]
15. Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers.
Reipold EI; Trianni A; Krakower D; Ongarello S; Roberts T; Easterbrook P; Denkinger C
BMC Infect Dis; 2017 Nov; 17(Suppl 1):702. PubMed ID: 29143612
[TBL] [Abstract][Full Text] [Related]
16. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.
Tan M; Bhadoria AS; Cui F; Tan A; Van Holten J; Easterbrook P; Ford N; Han Q; Lu Y; Bulterys M; Hutin Y
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):106-119. PubMed ID: 33197397
[TBL] [Abstract][Full Text] [Related]
17. A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.
Xiao Y; Wallace J; Thompson A; Hellard M; van Gemert C; Holmes JA; Croagh C; Richmond J; Papaluca T; Hall S; Hong T; Demediuk B; Iser D; Ryan M; Desmond P; Visvanathan K; Howell J
J Viral Hepat; 2021 Jun; 28(6):925-933. PubMed ID: 33662159
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
